Lumevoq

lenadogene nolparvovec · GenSight Biologics S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumevoq, covering 2023-08-08 to 2023-08-08. Get the full timeline:

Most recent: EMA Application withdrawn: Lumevoq (lenadogene nolparvovec) — GenSight Biologics S.A.